NasdaqGM - Nasdaq Real Time Price USD
Cronos Group Inc. (CRON)
2.7100 +0.0200 (+0.74%)
At close: June 24 at 4:00:02 PM EDT
2.7200 +0.0100 (+0.37%)
After hours: June 24 at 7:59:26 PM EDT
Trade CRON on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreChart Range Bar
Loading chart for CRON
Chart does not reflect overnight price.
- Previous Close
2.6900 - Open
2.7000 - Bid 2.3000 x 100
- Ask 3.0800 x 100
- Day's Range
2.6800 - 2.7300 - 52 Week Range
1.8800 - 3.4300 - Volume
1,030,066 - Avg. Volume
1,499,166 - Market Cap (intraday)
1.013B - Beta (5Y Monthly) 1.25
- PE Ratio (TTM)
∞ - EPS (TTM)
0.0000 - Earnings Date (est.) Aug 6, 2026
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
2.40
Recent News
View More
Performance Overview
Trailing total returns as of 6/24/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
CRON
3.44%
S&P/TSX Composite index (^GSPTSE)
9.01%
1-Year Return
CRON
43.39%
S&P/TSX Composite index (^GSPTSE)
30.01%
3-Year Return
CRON
49.72%
S&P/TSX Composite index (^GSPTSE)
78.88%
5-Year Return
CRON
69.99%
S&P/TSX Composite index (^GSPTSE)
71.83%
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
As of 6/24/2026
Market Cap
1.02B
Enterprise Value
197.04M
Trailing P/E
23.68
Forward P/E
26.11
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
6.50
Price/Book (mrq)
0.94
Enterprise Value/Revenue
1.24
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-1.14%
Return on Assets (ttm)
-0.78%
Return on Equity (ttm)
0.45%
Revenue (ttm)
159.54M
Net Income Avi to Common (ttm)
-1.82M
Diluted EPS (ttm)
0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
821.86M
Total Debt/Equity (mrq)
0.12%
Levered Free Cash Flow (ttm)
-15.45M
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
2.8300
-0.70%
Mkt Cap 175.296M
Industry Drug Manufacturers—Specialty & Generic
0.9217
-2.59%
Mkt Cap 413.305M
Industry Drug Manufacturers—Specialty & Generic
10.43
+0.38%
Mkt Cap 2.756B
Industry Drug Manufacturers—Specialty & Generic
0.9448
-0.65%
Mkt Cap 133.004M
Industry Drug Manufacturers—Specialty & Generic
4.5900
-0.43%
Mkt Cap 554.556M
Industry Drug Manufacturers—Specialty & Generic
7.03
-2.36%
Mkt Cap 1.539B
Industry Drug Manufacturers—Specialty & Generic
0.7730
+0.39%
Mkt Cap 286.396M
Industry Drug Manufacturers—Specialty & Generic
8.50
-0.35%
Mkt Cap 1.635B
Industry Drug Manufacturers—Specialty & Generic
5.67
-0.87%
Mkt Cap 419.116M
Industry Drug Manufacturers—Specialty & Generic
11.01
-7.25%
Mkt Cap 939.238M
Industry Drug Manufacturers—Specialty & Generic
Company Insights
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected. Learn more
Dividend Score
The distribution of earnings a company pays back to its shareholders based off the company’s profits. Usually paid out on a quarterly basis in the form of cash or additional stocks.
Hiring Score
A company’s hiring trends in key indicators can indicate how well the company is doing in terms of growing the company and where they are currently prioritizing.
Insider Sentiment Score
Vicker’s Insider Sentiment provides insights into trades made by insiders. This can be used to gain valuable insights and as a reflection of the prospect of the company based on insider trading.
Research Reports
View MoreCronos Group: Dropping Coverage
Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the US, the company has an option to acquire 5.9% of US multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.
RatingPrice TargetCronos Earnings: Shares Rally on Improved Results but We Don't Think the Stock Offers Much Upside
Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the US, the company has an option to acquire 5.9% of US multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.
RatingPrice TargetCannabis Sector Fares Terribly in 2024 US Elections, but Market Overreacts to Long-Term Impact
Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the US, the company has an option to acquire 5.9% of US multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.
RatingPrice TargetCronos Remains Far From Critical Mass to Achieve Profitability; Cash Hoard Is Most of Its Value
Cronos Group, headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the US, the company has an option to acquire 5.9% of US multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.
RatingPrice Target